TL;DR: Ansa Biotechnologies is a Y Combinator Winter 2020 startup Next-generation DNA synthesis using enzymes, currently active with a team of 72.
Next-generation DNA synthesis using enzymes
Last verified:
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Built by LemStudio
Yes. Ansa Biotechnologies was funded by Y Combinator in the Winter 2020 batch. Next-generation DNA synthesis using enzymes
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological re…
Ansa Biotechnologies was part of Y Combinator's Winter 2020 batch.
Ansa Biotechnologies has a team of 72 people according to Y Combinator's directory.
Ansa Biotechnologies is currently listed as Active with a team of 72 in Y Combinator's directory.
Loading interactive view…